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A Frailty Model for Projection of Human Mortality 
Improvements 
Shaun S. Wang* and Robert L. Brownt 
Abstract* 
Based on the everyday observations that individual human beings vary sig-
nificantly in their capacity to combat death, we adopt a so-called frailty model 
of human mortality. This frailty model assumes that each individual in a given 
population is endowed with his or her own frailty index, r, which remains con-
stant for life. In addition, we assume that the individual's force of mortality 
(hazard rate function) at age x, /Jx(r), satisfies /Jx(r) = r/Jx where /Jx is the 
population's base force of mortality at age x. Given the probability distribution 
of the frailty index among the newborns in the population, an expression is 
given for the distribution of the frailty index among the survivors reaching age 
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x in the population. Finally, assuming that (i) the rate of mortality improve-
ment for any age is proportional to the average frailty level of the indiViduals 
at that age, (ii) a gamma distribution for the frailty index, and (iii) a Gompertz 
form for the population's base force of mortality, we graduate (smooth) the ob-
served mortality improvement factors in the published Society of Actuaries' 
GAR-94 Table. 
Key words and phrases: force of mortality, hazard rate, gamma distribution, 
Gompertz law 
1 A Review of Actuarial Mortality Projection 
Throughout most of the twentieth century (except during periods of 
famine, war, and other civil strife), there has been a long and consistent 
trend of mortality improvement. Lancaster (1990, Chapter 3.6, Table 
3.6.1) shows the persistent decline in the overall mortality in several 
western countries. The reason for this decline is largely because of 
improvements in public health, improvements in the production and 
distribution of food, and advances in medicine and technology. 
Interestingly, Vaupel and Yashin (1987, pp. 123) note that progress 
in reducing mortality can be conceived in two ways. Demographers 
generally view mortality change as change in the force of mortality and 
associated life table statistics for a population. Most relative layper-
sons, on the other hand, especially physicians and other health and 
safety personnel, perceive a reduction in mortality as being achieved 
by saving the lives of individuals faced with death. A demographer 
might report that the force of mortality at age fifty among U.S. males 
was cut in half from 1900 to 1980, from 1.6 percent to 0.8 percent. 
A public health specialist might focus attention on the lives that were 
saved in 1980 compared with 1900 because of new surgical and medi-
cal procedures, the introduction of penicillin, polio vaccines, and other 
pharmaceuticals, better nutrition and sanitation, improved automotive 
safety, a decrease in cigarette smoking, faster and more effective am-
bulance service, and so on. 
Actuaries, like demographers, generally view mortality change as 
change in the force of mortality and associated life table statistics for a 
population. In fact, the projection of mortality improvement has been 
an important subject to actuaries. For example, in the first issue of the 
Transactions of the Society of Actuaries Jenkins and Lew (1949) give a 
lengthy discussion on this subject. Over the past few decades, vari-
ous methods have been suggested by actuaries and demographers to 
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project age-specific mortality rates. Pollard (1987) gives an excellent 
review of these methods. We only summarize methods adopted by ac-
tuaries in North America and the United Kingdom in the projection of 
future mortality rates. 
1.1 The American Approach 
The Society of Actuaries 1994 Group Annuity Reserving Table (GAR-
94) 1 has adopted a generation life table approach to project mortality 
improvement. 
Let qI be the mortality rate observed at age x in calendar year z. 
Mortality improvement implies that the mortality rates for age x in 
future years form a non-increasing sequence in z. In the GAR-94 Table 
this implies that: 
Let AAI denote the annual improvement factor in the mortality rate for 
age x from calendar year z to z + 1, i.e., 
z+l AA~ = 1- q\ . 
qx 
The GAR-94 Table assumes that at each age the AAI = AAx , a constant, 
as z increases: 
q1995 q1996 q1997 
1994 = 1995 = 1996 = ... = 1 - AAx. qx qx qx 
(1) 
To produce the mortality rate for a person age x in year (1994 + n), the 
following formula is used: 
(2) 
To assist in mortality projections using equation (2), the Society of 
Actuaries published the 1994 mortality rates as the base table, coupled 
with the improvement factors AAx. Some values of qx and AAx for 
IThe 1994 Group Annuity Mortality Table and the 1994 Group Annuity Reserving 
Table are published by the Society of Actuaries Group Annuity Valuation Table Task 
Force in Transactions of the Society of Actuaries, 47 (1995): 865-913. 
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males at ages x = 50, ... ,99 are listed in Table 1 (where the values of 
qx contain no margin). Specifically, Table 1 is an extract of the Society of 
Actuaries 1994 Group Annuity Reserving Table (the SOA GAR-94 Table) 
with: (i) base mortality rates qx, (ii) improvement factors AAx , and (iii) 
implied rate of improvement Ex. 
1.2 The British Approach 
Based on the mortality experience in the United Kingdom, British 
actuaries have developed a more sophisticated method of projecting 
mortality.2 Using the 1980 mortality rates as the base table, continuing 
improvement in mortality beyond 1980 is modeled as: 
q~ = q1980 {a(x) + [1- a(x)](O.4)Z-~680}, 
where z is the calendar year, and 
Note that 
and 
{ 
0.5, 
x-10 
a(x) = 1100' 
x < 60 
60::s; x::s; 110 
x> 110. 
lim qZ = a(x)q1980, 
z-oo x x 
z+I-1980 
AAz = 1 _ a(x) + [1 - a(x)](0.4)-2-0-
x z-\980 
a(x) + [1- a(x)](O.4)------ZO 
is a decreasing function of z. 
(3) 
(4) 
(5) 
Equation (3) has three characteristics: (i) mortality improvement de-
clines with advancing age; (ii) the mortality rate declines exponentially 
with the passage of time to a long-term limiting value; and (iii) the mor-
tality improvement exhibits a decelerating trend. 
2See Continuous Mortality Investigation Bureau (CMIB). "Standard Tables of Mortal-
ity Based on the 1979-82 Experiences." Continuous Mortality Investigation Reports, 10 
(1990): 1-138. 
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Table 1 
Excerpt of the Society of Actuaries' 
Male 1994 Group Annuity Reserving Table (SOA GAR-94) 
x qx AAx Ex x qx AAx Ex 
50 0.002773 0.018 0.01802 75 0.040012 0.014 0.01429 
51 0.003088 0.019 0.01903 76 0.043933 0.014 0.01431 
52 0.003455 0.020 0.02003 77 0.048570 0.013 0.01332 
53 0.003854 0.020 0.02004 78 0.053991 0.012 0.01234 
54 0.004278 0.020 0.02004 79 0.060066 0.011 0.01134 
55 0.004758 0.019 0.01904 80 0.066696 0.010 0.01035 
56 0.005322 0.018 0.01805 81 0.073780 0.009 0.009351 
57 0.006001 0.017 0.01705 82 0.081217 0.008 0.008346 
58 0.006774 0.016 0.01605 83 0.088721 0.008 0.008380 
59 0.007623 0.016 0.01606 84 0.096358 0.007 0.007364 
60 0.008576 0.016 0.01607 85 0.104559 0.007 0.007398 
61 0.009663 0.015 0.01507 86 0.113755 0.007 0.007437 
62 0.010911 0.015 0.01508 87 0.124377 0.006 0.006414 
63 0.012335 0.014 0.01409 88 0.136537 0.005 0.005384 
64 0.013914 0.014 0.01410 89 0.149949 0.005 0.005427 
65 0.015629 0.014 0.01411 90 0.164442 0.004 0.004380 
66 0.017462 0.013 0.01311 91 0.179849 0.004 0.004422 
67 0.019391 0.013 0.01313 92 0.196001 0.003 0.003351 
68 0.021354 0.014 0.01415 93 0.213325 0.003 0.003389 
69 0.023364 0.014 0.01416 94 0.231936 0.003 0.003432 
70 0.025516 0.015 0.01519 95 0.251189 0.002 0.002319 
71 0.027905 0.015 0.01521 96 0.270441 0.002 0.002350 
72 0.030625 0.015 0.01523 97 0.289048 0.002 0.002383 
73 0.033549 0.015 0.01525 98 0.306750 0.001 0.001207 
74 0.036614 0.015 0.01528 99 0.323976 0.001 0.001224 
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1.3 The Frailty Approach 
Most actuarial and demographic techniques for projecting mortality 
rates are based on the extrapolation of past mortality rates. Few mathe-
matical formulations are based on the underlying biological mechanism 
of mortality improvement. 
Traditional life table methods, after accounting for factors such as 
race, gender, and smoking status, implicitly assume that the popula-
tion is homogeneous, an assumption that is usually unrealistic. Empir-
ical evidence shows that the following factors significantly affect mor-
tality rates: genetics, economic status, education, marital status, and 
lifestyle. If mortality is not classified according to these additional risk 
factors, then the group's mortality characteristic will be heterogeneous. 
For practical reasons not all of the above risk factors are usually in-
cluded in mortality estimates. Thus, it is important to examine the con-
sequences of heterogeneity when interpreting observed mortality rates 
and mortality improvements (Vaupel et al., 1979; Hougaard, 1991). A 
formal mathematical account of the treatment of heterogeneity can be 
found in Hougaard (1984,1995) and the text of Namboodiri and Suchin-
dran (1987). 
Vaupel et al. (1979) propose a frailty model to study the effect of 
heterogeneity on cohort mortality rates.3 In their model, each individ-
ual in a given population is endowed with his or her intrinsic frailty 
index, r, which is assumed to remain constant for life. An individual 
age x with frailty index r has force of mortality (hazard rate function), 
Ilx(r), which is assumed to satisfy 
Ilx(r) = rll(x) (6) 
where Ilx is the population's base force of mortality at age x. Weak 
(strong) individuals are associated with high (low) values of r. 
2 Measurement of Mortality Improvement 
To facilitate an easier discussion of mortality improvements, the 
following notational style is used: 
3This frailty model can be viewed as a special version of the Cox (1972) proportional 
hazard model in the context of an unobserved covariate. Norberg (1989) uses a propor-
tional hazard model for the heterogeneity in group life insurance. Two early actuarial 
applications of the frailty model that merit mentioning are Redington (1969) where 
there is a range of sample calculations, and Beard (1971) where the Gamma-Gompertz 
model is analysed. 
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• x denotes the current age and is placed at the right subscript; 
• z denotes the current calendar year and is placed at the right su-
perscript; 
• A bar (-) placed on top of a quantity indicates that it is for a group 
of individuals; and 
• A hat () placed on top of a quantity indicates that it is the esti-
mated or observed value. 
For example, fJ.~ represents the estimated or observed hazard rate for 
an individual at age x, at calendar time z. 
Customary measures of progress in mortality consider only changes 
in mortality rates q~ over different calendar years. Vaupel et al. (1979) 
argue that this may not be the most informative measure for mortal-
ity improvement. Instead of measuring progress in terms of mortality 
rates, Vaupel et al. state that it may be more appropriate to measure 
such progress in terms of the hazard rate (force of mortality) for stan-
dard individuals. Vaupel et al. (1979) give two main reasons: 
1. For the frailty model of equation (6), the ratio of the Ji'S measures 
mortality progression at any level of frailty because the ratio is 
independent of r: 
Ji~+n(r') 
JiYc(r') . 
However, this is not true for the ratio of the q's, i.e., the ratio 
depends on r: 
2. In youth and middle age, when Jix and qx are close to zero, Jix 
is approximately equal to qx. At the elderly ages, however, Jix, 
which is not bounded by 1, can greatly exceed qx. As a result, 
progress that substantially reduces Jix may have much less effect 
on qx. For example, consider a reduction in Jix from 2 to 1: if 
these values of Jix stayed constant over the course of a year, qx 
would only be reduced from 0.86 to 0.63. 
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For an integer age x, we define annual improvement factors E; in 
terms of hazard rates 
-z+1 1 (1 -2+1) 
EZ = 1 _ 11 x+O.5 = 1 _ og - qx 
x 7l~+O.5 log (1 - q~) (7) 
where a constant hazard rate function is assumed for the age interval 
(x,x + 1). 
In the GAR-94 Table, the improvement factor AAx is measured by 
the ratio of the observed mortality rates: 
(8) 
The implied improvement factor £1994 is 
£1994 = I_log[I- £11994 (I-AAx )] 
x log[I _ £11994] (9) 
Table 1 shows the values of £1994 for comparison with the values of 
AAx. From Table I, one can see that the values of £1994 do not deviate 
much from AAx for ages below 85. However, the relative difference be-
comes significant beyond age 85 and may affect our estimate of annuity 
costs (as they are based on mortality projections many years into the 
future). 
3 A Mathematical Model for Frailty 
3.1 The Basic Model 
Consider a cohort of newborns (age exactly 0) where their survival 
capacity varies across individuals. A standard newborn is one whose 
future lifetime, X, has a force of mortality I1x and cumulative force of 
mortality 
Hx = f: I1t dt . (10) 
Each individual has his/her unknown constant frailty index r with force 
of mortality given in equation (6). Thus a standard newborn has r = 1. 
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To model the heterogeneity of frailty for the cohort of newborns age 
exactly 0, let Ro be the unknown frailty index of an individual chosen at 
random from the cohort of newborns. Assume that Ro has a probability 
density function (pdf) Bo(r) for r > 0. 
For a newborn with frailty r, the (conditional) survivor function and 
(conditional) pdf are: 
Pr[X> xlRo = r] 
j(xlr) 
The joint density of X and Ro is 
and the unconditional probability of a newborn chosen at random sur-
viving to age x is 
Pr[X> x] S(x) 
fo"o S(xlr) Bo(r)dr 
fooo e-rHx Bo(r)dr 
Mgo(-Hx}, 
where MgO (8) is the moment generating function Ro, i.e., 
Mgo(8) = E[e BRO ] = fo
oo 
e-rB Bo(r)dr. 
From S(x) we can get j(x), the pdf of X, 
j(x) = J.1x fooo re- rHx Bo(r)dr, 
and Jix, the force of mortality associated with S (x), 
(11) 
(12) 
(13) 
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Next we turn our attention to the survivors age exactly x from the 
cohort of newborns. Clearly the distribution of the frailty index among 
these survivors will not necessarily be the same as at age 0 because 
one would expect more of the weaker ones to have died earlier. So 
the population at age x should have a larger percentage of stronger 
individuals. 
Let Rx be the frailty variable for the survivor cohort at age x chosen 
at random. Rx has pdf Bx(r) given by 
Bx(r) = S(x!r)Bo(r) = e-rHx Bo(r). 
S(x) Mgo(-Hx) (14) 
Thus the average frailty for the survivor cohort at age x is 
Rx = E[R
x
] = fo
oo 
re-
rHx Bo (r)dr = Tix 
Mgo(-Hx) J1x (15) 
Note that Tix = J1xRx, i.e., the force of mortality for [X > x] is always 
equal to the force of mortality of the standard individual multiplied by 
the average frailty among the survivors. 
Among those who die at age x (Le., in (x, x + dx)), the frailty index 
has a conditional density: 
j(x, r) r e-rHx Bo(r) 
j(x) = fooore-rHxBo(r)dr' (16) 
3.2 Gamma Frailty Density 
Because of its mathematical tractability and its flexible shape, the 
gamma distribution has been used by many authors (including Vaupel 
et al., 1979) to model the frailty variable. Specifically we assume that 
Ro has a gamma density: 
(17) 
where ()( > -1 is a shape parameter and f3 > 0 is a scale parameter. The 
moment generating function is 
Mgo((J) = (f3 ~ e) ()( 
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The first two moments of Ro are: 
- ()( 
Ro = E[Ro] = Ii' and 2 ()( (J (Ro) = f32' 
From equation (14) Rx is also gamma distributed with shape param-
eter ()( and a different scale parameter f3 + Hx· 
In this case, the mean frailty of the survivors at age x is 
- ()( 
Rx = f3 + Hx' 
From equation (16), the frailty index for those who die in (x, x + dx) 
has a conditional density that is also gamma distributed, with a shape 
parameter ()( + 1 and a scale parameter f3 + Hx. In this case, the mean 
frailty of those who die is: 
- ()(+1 
Rxx--, 
()( 
which is greater than the mean frailty of the survivors. 
3.3 Gompertz's Law 
Assume that the standard individual's lifetime follows Gompertz's 
law: 
J.lx = bcx log(c), Hx = b(cX - 1). (18) 
Gompertz's law has been used by actuaries since 1825. Several biologi-
cal theories of aging have been developed that imply a Gompertz form 
of hazard rates (see Strehler, 1977, Chapter 5). Brillinger (1961) argues 
that if the human body is considered as a series system of independent 
components, then the hazard rate function may follow the Gompertz 
law (also see Carriere, 1992). 
If the frailty variable Ro is assumed to have a gamma density in equa-
tion (17), then the birth cohort has an unconditional survivor function 
- ( f3 )iX 
S(x) = f3 + b(cX - 1) , 
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and hazard rate function 
_ ()( b eX log(e) 
/-Lx = {3 + b(e X - 1)' (19) 
Equation (19) is derived in the manner used by Beard (1971), and is one 
of the "laws" of mortality originally proposed by Perks (1932). 
Pollard (1980,1993) studies the case where each individual in a pop-
ulation has a hazard rate function of the Gompertz type. Note that the 
cohort hazard rate function in equation (19) increases exponentially ini-
tially, but the growth rate decreases with advancing age. Pollard points 
out that this is a phenomenon observed in many populations. 
Among the survivors age x, Rx has a gamma distribution with a 
shape parameter ()( and a scale parameter {3 + b(eX - 1). The mean 
frailty for the survivors age x is 
- ()( 
Rx = -{3-+-b-(-e-X ---1-)' 
4 A Model for Mortality Improvement 
In a given calendar year, the overall level of mortality improvement 
depends on the marginal changes of many external factors such as med-
ical technology and its availability to the general public. In general, pro-
jection of these external factors for future years is a difficult task and 
requires more detailed (perhaps non-actuarial) investigation. In this pa-
per we are concerned mainly with the rates of mortality improvement 
among different cohorts in a given calendar year, where the same un-
derlying external factors apply to all ages. 
We hypothesize that mortality improvements due to the marginal 
advancement of life-saving techniques progress as follows: 
Hypoyhesis 1. For each age x the rate of improvement in terms of the 
force of mortality (hazard rate) is proportional to the average frailty Rx. 
This hypothesis is based on the argument that marginal improve-
ments in life-saving techniques have relatively larger effect on frailer 
individuals with higher than average values of r. Most deaths of strong 
individuals with lower than average values of r are due to natural aging; 
thus, improvements in life-saving techniques or better health-practices 
would have relatively smaller effects on healthier individuals, Le., those 
with lower than average values of r. 
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Assume that, for each birth cohort at time y, frailty has a gamma 
density with: 
where ()( = {3. 
If we assume Gompertz mortality for a standard individual, the mean 
frailty of the survivors at age x, at calendar time z = y + x, is 
RZ = ()( 
x ()( + b (eX - 1) 
Based on the above hypothesis, the improvement factor E~ is propor-
tional to the average frailty of the survivor cohort at age x: 
Z -z ()( 
Ex = K Rx+O.5 = K ()( + b(ex+O.5 _ 1)' (20) 
where K is a constant, and an adjustment of a half year is used because 
E~ is measured by the ratios of mid-year hazard rates. 
Equation (20) of E~ implies that, at any fixed calendar time, the mor-
tality improvement decreases rapidly at advanced ages, due to the ex-
ponential growth in Hx = b(e X - 1) with age. 
5 Fitting the Gamma-Gompertz Model 
Now we will fit the Gamma-Gompertz model to the GAR-94 Base Ta-
ble, which gives the cohort age-specific mortality rates. Neither frailty 
nor heterogeneity was discussed in the GAR-94 Table. Specifically, we 
assume Gompertz's law for each individual's force of mortality. 
Suppose that the cohort is homogeneous and each individual's life-
time follows the Gompertz law with f.lx = B eX. We would expect that 
e[x] = [f.lX+20.5]io 
f.lx+O.5 
be approximately constant. 
From the GAR-94 mortality rates, we have calculated the values of 
e[x] at different ages (see Table 2). As shown in Table 2, the values 
of e[x] exhibit a gradual decreasing trend as age increases. Although 
there are many possible explanations to this observed pattern, we will 
try to fit the mortality rates to a frailty (heterogeneous) model. 
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Table 2 
Calculated Values of c[x] 
x c[x] x c[x] 
50 1.1180 60 1.1097 
51 1.1171 61 1.1088 
52 1.1160 62 1.1076 
53 1.1151 63 1.1059 
54 1.1142 64 1.1040 
55 1.1133 65 1.1023 
56 1.1124 66 1.1010 
57 1.1114 67 1.1005 
58 1.1107 68 1.1006 
59 1.1102 69 1.1012 
5.1 Fitting the 1994 Base Mortality Rates 
Based on considerations that mortality rates at advanced ages may 
not be as accurate due to smaller sample sizes, we suggest using some 
representative age range, say, from 50 to 75. For many populations, 
from the mortality rates at ages 50 and 70, one can get a good approxi-
mation of the shape of the mortality curve at all ages (Benjamin, 1982; 
Pollard, 1991 and 1993). 
We assume that the standard force of mortality follows the Gom-
pertz law with 
/lx = bcx log(c), Hx = b(cX - 1). 
Furthermore, we will choose /lx such that Ro = 1. 
We define a measure for goodness of fit by using the sum of squared 
errors for ages from 50 to 75: 
where 
75 
DIST50:75 = I (71x+o.5 - /1x+O.5)2 
x=50 
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can be obtained from the mortality rates in Table 1. 
Assume that Ro has a gamma density, then Ro = 1 implies 0< = f3 so 
that 
_ o<bcx log(c) 
JJx= 0<+b(c X -1)' (21) 
By minimizing DISTso:7s, we get the following estimate of the un-
known parameters: 
c = 1.1248, b = 0.66 X 10-4 , 0< = 1.306, (22) 
with the minimum distance being 
min{DISTsO:7s} = 0.2238 x 1O-s. 
We have noticed that the estimation of parameters for the frailty 
distribution (mixing density) is not very robust, depending on the age 
range used in the estimation of parameters. This is a common phe-
nomenon in many mixture models (Chan, 1995; Manton et al., 1986; 
Everitt and Hand, 1981). 
5.2 Fitting the GAR-94 Mortality Improvement Factors 
We shall use a Gamma-Gompertz model for the 1994 base mortality 
rates and adopt the particular set of estimated parameters in equation 
(22) in the Gamma-Gompertz model: 
c = 1.1248, b = 0.66 X 10-4 , 0< = 1.306. 
The frailty model of mortality improvement in equation (20) suggests 
the following pattern for the improvement factors: 
1994 1.306 
Ex = K x 1.306 + 0.66 x 10-4 x (1.1248x+o.s - 1)' 
Now we use this frailty model of mortality improvement to fit the em-
pirical improvement factors £1994 in Table 1. We are mainly interested 
in the mortality improvement at senior ages, say, 50 and above. We first 
choose an age range from 50 through 95 and define a loss measure: 
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95 
M50:95 = L (E;994 - E;994)2. 
x=50 
The ages below 50 are excluded because of the sudden dip in the ob-
served improvement factors (see Figure 1) which may be a result of 
other exogenous factors (e.g., aCcident, AIDS). The ages beyond 95 are 
not included because of the scarcity of available data for extreme ages 
95 and above. 
By minimizing the loss measure M50:95, we get a least square esti-
mate for K: 
I~g (E;994) (E;994) 
K = 95 1994 = 0.01769. I 50 (Ex )2 
Table 3 compares the Gamma-Gompertz frailty model improvement 
factors Ex and the empirical improvement factors Ex in the GAR-94 ta-
ble. Figure 1 also displays these improvement factors. Note that in fig-
ure 1 the Exs in the GAR-94 Table do not follow a smooth pattern. Also, 
there is inSignificant mortality improvement in the 25-45 age group.4 
Beyond age 50 the frailty model seems to be an acceptable fit and may 
provide a theoretical basis for the observed improvement factors. The 
frailty model of mortality improvement has the definite advantage that 
the projected mortality rates are smooth. 
The choices of the age range, from 50 to 95, and the loss measure 
(Le., the squared error) are arbitrary and are for illustration purposes 
only. One may use other age ranges or weighted squared error, as ap-
propriate. 
6 Other Evidence 
According to United Nations 1991,5 in developed countries, one half 
of female and one-third of male deaths now occur after age 80. The 
mortality reductions within this age range are crucial in determining 
changes in life expectancy and actuarial annuity values. 
4This could be attributed to extra AIDS deaths in the 25-45 age group. 
sUnited Nations Demographic Yearbook 1991. New York: United Nations 
Wang and Brown: A Frailty Model 237 
Table 3 
Mortality Improvement Rates 
x Ex Ex x Ex Ex 
50 0.017410 0.018030 75 0.013520 0.014290 
51 0.017370 0.019030 76 0.013130 0.014320 
52 0.017330 0.020030 77 0.012720 0.013330 
53 0.017290 0.020040 78 0.012290 0.012340 
54 0.017240 0.020040 79 0.011840 0.011340 
55 0.017180 0.019050 80 0.011370 0.010350 
56 0.017120 0.018050 81 0.010890 0.0093500 
57 0.017050 0.017050 82 0.010390 0.0083500 
58 0.016980 0.016050 83 0.0098800 0.0083800 
59 0.016890 0.016060 84 0.0093700 0.0073600 
60 0.016800 0.016070 85 0.0088500 0.0074000 
61 0.016690 0.015070 86 0.0083300 0.0074400 
62 0.016580 0.015080 87 0.0078100 0.0064100 
63 0.016450 0.014090 88 0.0073100 0.0053800 
64 0.016310 0.014100 89 0.0068100 0.0054300 
65 0.016150 0.014110 90 0.0063200 0.0043800 
66 0.015980 0.013110 91 0.0058500 0.0044200 
67 0.015790 0.013130 92 0.0054000 0.0033500 
68 0.015580 0.014150 93 0.0049700 0.0033900 
69 0.015350 0.014160 94 0.0045600 0.0034300 
70 0.015100 0.015190 95 0.0041800 0.0023200 
71 0.014830 0.015210 96 0.0038200 0.0023500 
72 0.014530 0.015230 97 0.0034800 0.0023800 
73 0.014220 0.015260 98 0.0031600 0.0012100 
74 0.013880 0.015280 99 0.0028700 0.0012200 
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Figure 1 
Mortality Improvement Factors Ex for GAR-94 
And Ex for the Frailty Model 
o 20 40 60 80 
Age x 
100 
Kannisto et al., (1994) study the reduction in mortality at advanced 
ages based on a large and reliable database for 27 countries, 1960s 
through 1980s. The follOwing is cited from Kannisto et al., (1994, pp. 
801): 
For nine countries - Austria, Belgium, England and Wales, 
West Germany, France, Japan, Scotland, Sweden, and Switzer-
land - data are available through 1991. A glimpse at the most 
recent trends is provided by calculating the annual average 
rate of mortality improvement between 1982-86 and 1987-
91 for this aggregate of nine countries. For males the rate of 
improvement was 1. 7 percent for octogenarians and 1.2 per-
cent for nonagenarians; for females the corresponding rates 
were 2.5 percent and 1.6 percent. 
Even though the magnitude of the mortality improvement at ad-
vanced ages is higher than those in the GAR-94 Table, the general pat-
tern of deceleration of mortality improvement at advanced ages is con-
sistent with our frailty model of mortality improvement. 
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In a panel discussion of mortality trends, Moriyama (1967) also pro-
vides evidence that the rate of improvement in mortality rates decreases 
at advanced ages. 
7 Closing Comments 
The main contribution of this paper is the utilization of a frailty 
model to derive mathematical formulae for mortality improvement fac-
tors. As marginal advancement in life-saving techniques determines 
the pace of mortality improvement, we assume that weaker individuals 
are more likely to benefit from these advances than are stronger indi-
viduals. This assumption is supported in the demography literature 
(Vaupel and Yashin, 1985). To project the future trend of mortality 
improvement, one needs to assess carefully the future advancement in 
medical technology. A major breakthrough in medical technology or an 
unexpected new epidemic may have a sudden impact on the mortality 
improvement. 
Several authors, including Bowers et aI., (1986) and London (1985), 
have discussed the importance of smoothness in mortality rates. Their 
arguments for smoothness can be extended to mortality improvement 
factors. Our frailty model provides useful mathematical formulae for 
graduation of empirical improvement factors. 
One potential shortcoming of our model is that the frailty index is 
assumed to be determined at birth and remains constant for life. Intu-
ition suggests, however, that this assumption may be overly simplistic. 
In future studies, the concept of frailty may be modeled as a variable 
dependent upon exogenous observable factors such as lifestyle, envi-
ronment, economic status, or marital status. 
We hope this paper stimulates further research on this important 
subject. 
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